Correction: Bone marrow-derived mesenchymal stem cells: a potential therapy in an autoimmune hepatitis rat model

Abstract

This corrects "Bone marrow-derived mesenchymal stem cells: a potential therapy in an autoimmune hepatitis rat model." Adv. Life Sci. 2025 Feb;12(1):105–113. doi: 10.62940/als.v12i1.3171.

Following the publication of this article, an internal audit — conducted in response to quality concerns raised by Web of Science — identified concerns regarding the quality of figures in the originally published version. Higher DPI versions of the figures have since been provided and appended at the end of the Results section in the HTML version of the article. The Editorial Expression of Concern issued on 20 May 2025 has accordingly been withdrawn. The earlier published copy of this article is available on request at als.editor@als-journal.com.

The Advancements in Life Sciences Editorial Office regrets that these issues were not identified prior to publication.

History of the correction process

Editorial Expression of Concern

20 May 2025: Following publication of this paper, the internal audit (consequent to concerns on quality raised by Web of Science) notified Advancements in Life Sciences about quality of figures. By this Editorial Expression of Concern, we alert the scientific community of the errors as we refurnish figures with higher DPI.

Correction Published

28 May 2025: The necessary corrections have been carried out in the Version of Record.